WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on1 OCTOBER 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

  Indexing

  • Google Scholar
  • Index Copernicus
  • SOCOLAR, China
  • Research Bible, Fuchu, Tokyo. JAPAN
  • Cosmos Impact Factor
  • Scientific Indexing Services (SIS)
  • UDLedge Science Citation Index
  • International Impact Factor Services
  • International Society for Research Activity (ISRA) Journal Impact Factor (JIF)
  • Scientific Journal Impact Factor (SJIF)
  • IFSIJ Measure of Journal Quality
  • International Scientific Indexing, UAE (ISI) (Under Process)
  • International Impact Factor Services (IIFS)
  • Web of Science Group (Under Process)
  • Directory of Research Journals Indexing
  • Scholar Article Journal Index (SAJI)
  • International Scientific Indexing ( ISI )
  • Academia
  • Scope Database
  • Research Publication Rating and Indexing
  • Doi-Digital Online Identifier
  • ISSN National Centre
  • Zenodo Indexing
  • International CODEN Service, USA

Abstract

IMPACT OF RHEUMATOID ARTHRITIS ACTIVITY ON CARDIOVASCULAR RISK PREDICTION AND STATIN ELIGIBILITY: A MULTI-SCORE STUDY FROM IRAQ

*Hayder Ahmed Ali Maghaza, Fadhil Hani Abbas, Nadia Tariq Zaidan

ABSTRACT

Background: Cardiovascular disease risk is elevated in rheumatoid arthritis, which is a chronic inflammatory disorder affecting the entire body. Minimizing the occurrence of cardiovascular events in individuals with rheumatoid arthritis requires precise cardiovascular risk evaluation in addition to suitable statin treatment. However, because they do not account for rheumatoid arthritis specific variables, conventional cardiovascular risk calculators may understate risk. Aim of study: To evaluate the cardiovascular risk using several methods in rheumatoid arthritis patients, including determining the prevalence of patients who should be on statins and estimate the patients who achieve their lipids targets. Methods: A cross-sectional study was conducted on 430 rheumatoid arthritis patients in Baghdad Teaching Hospital during a period of two years from April 2024 till April 2026. Cardiovascular risk was assessed using QRISK-3, ASCVD, and Adjusted Framingham Score. Data on demographics, disease activity (DAS28), clinical, and laboratory variables were collected. Statin eligibility was determined according to each risk tool’s thresholds. Results: In this study, total eligibility for statins was 33.5%, with percentages varying by risk calculator: 31.6% according to QRISK-3, 22.3% according to ASCVD, and 6.3% according to AFS. With rheumatoid arthritis disease activity, the percentage of patients indicated to take a statin shot grew dramatically, reaching 76.8% of the most active individuals. Female gender, obesity, smoking, corticosteroid use, and high cholesterol were independent predictors of statin therapy. Conclusions: Cardiovascular risk assessment in rheumatoid arthritis patients depends heavily on the risk tool used, with QRISK-3 showing greater sensitivity likely due to inclusion of rheumatoid arthritis as a risk factor. Rheumatoid arthritis disease activity is strongly associated with higher cardiovascular risk and statin eligibility. These findings support the need for rheumatoid arthritis specific risk assessment in clinical practice.

[Full Text Article] [Download Certificate]